secwatch.observer — SEC 8-K summary
======================================

Issuer:     VACCINEX, INC. (VCNX)
CIK:        0001205922
Form:       8-K
Filed at:   2023-09-13T23:59:59+00:00
Accession:  0001193125-23-233884
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Vaccinex shareholders approve 1:15 reverse stock split; board sets ratio, effective Sept 2023
--------------------------------------------------------------------------------

- Stockholders approved reverse stock split amendment with 43,464,926 votes for, 2,041,760 against, 135,207 abstained.
- Board set reverse split ratio at 1:15; effective date expected in September 2023, subject to final determination.
- Prior to effective time, company will disclose final timing and additional details.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1205922/000119312523233884/0001193125-23-233884-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1205922/000119312523233884/d553987d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-233884

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer